Post-earnings recap
Reported
Wed, Aug 3, 2022
Est. EPS
—
Est. revenue
—
Implied move
—
EPS beat rate
75%
Moderna's strong EPS performance indicates better-than-expected profitability, which likely contributed to the stock's significant rise of nearly 16%. However, the lack of revenue figures and guidance leaves some uncertainty about future performance. Investors may be optimistic about the company's ongoing projects and potential developments in the pipeline.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $5.24 | N/A | +17.81% |
| Revenue | N/A | N/A | N/A |
Management highlighted the positive EPS surprise as a sign of resilience. They remain focused on future product developments and market opportunities.
Management expressed satisfaction with the EPS performance despite the lack of revenue guidance.
They emphasized ongoing research and development efforts in the pipeline.
—
Est. EPS
—
Est. Rev
—
Impl. Move
—